Hydroxychloroquine Potentiates Apoptosis Induced by PPARα Antagonist in 786-O Clear Cell Renal Cell Carcinoma Cells Associated with Inhibiting Autophagy

Clear cell renal cell carcinoma (ccRCC) is the major pathological pattern of renal cell carcinoma. The ccRCC cells exhibit a certain degree of inherent drug resistance due to some genetic mutations. In recent years, peroxisome proliferator-activated receptor-α (PPARα) antagonists have been reported...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruizhe Mao, Jian Shi, Xuyi Ma, Haiyan Xu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2021/6631605
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561809900437504
author Ruizhe Mao
Jian Shi
Xuyi Ma
Haiyan Xu
author_facet Ruizhe Mao
Jian Shi
Xuyi Ma
Haiyan Xu
author_sort Ruizhe Mao
collection DOAJ
description Clear cell renal cell carcinoma (ccRCC) is the major pathological pattern of renal cell carcinoma. The ccRCC cells exhibit a certain degree of inherent drug resistance due to some genetic mutations. In recent years, peroxisome proliferator-activated receptor-α (PPARα) antagonists have been reported as a targeted therapeutic drug capable of inducing apoptosis and cell cycle arrest in the ccRCC cell line. Autophagy, which can be induced by stress in eukaryotic cells, plays a complex role in the proliferation, survival, and death of tumor cells. In our study, we found that the expression of PPARα was low in highly differentiated ccRCC tissues and 786-O cell line but high in poorly differentiated ccRCC tissues. The level of PPARα expression in ccRCC tissues is correlated to the grade of differentiation, but not to the sex or age of ccRCC patients. The findings also revealed that the PPARα antagonist GW6471 can lower cell viability and induce autophagy in the 786-O ccRCC cell line. This autophagy can be inhibited by hydroxychloroquine. When treated with a combination of hydroxychloroquine and GW6471, the viability of the 786-O cells was decreased further when compared to the treatment with GW6471 or hydroxychloroquine alone, and apoptosis was promoted. Meanwhile, when human kidney 2 cells were cotreated with hydroxychloroquine and GW6471, cell viability was only slightly influenced. Hence, our finding indicates that the combination of GW6471 and hydroxychloroquine may constitute a novel and potentially effective treatment for ccRCC. Furthermore, this approach is likely to be safe owing to its minimal effects on normal renal tissues.
format Article
id doaj-art-e71954ad67f147b4a66cecf79e1dc832
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-e71954ad67f147b4a66cecf79e1dc8322025-02-03T01:24:13ZengWileyPPAR Research1687-47571687-47652021-01-01202110.1155/2021/66316056631605Hydroxychloroquine Potentiates Apoptosis Induced by PPARα Antagonist in 786-O Clear Cell Renal Cell Carcinoma Cells Associated with Inhibiting AutophagyRuizhe Mao0Jian Shi1Xuyi Ma2Haiyan Xu3Laboratory of Urology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, ChinaLaboratory of Urology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, ChinaLaboratory of Urology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, ChinaLaboratory of Urology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, ChinaClear cell renal cell carcinoma (ccRCC) is the major pathological pattern of renal cell carcinoma. The ccRCC cells exhibit a certain degree of inherent drug resistance due to some genetic mutations. In recent years, peroxisome proliferator-activated receptor-α (PPARα) antagonists have been reported as a targeted therapeutic drug capable of inducing apoptosis and cell cycle arrest in the ccRCC cell line. Autophagy, which can be induced by stress in eukaryotic cells, plays a complex role in the proliferation, survival, and death of tumor cells. In our study, we found that the expression of PPARα was low in highly differentiated ccRCC tissues and 786-O cell line but high in poorly differentiated ccRCC tissues. The level of PPARα expression in ccRCC tissues is correlated to the grade of differentiation, but not to the sex or age of ccRCC patients. The findings also revealed that the PPARα antagonist GW6471 can lower cell viability and induce autophagy in the 786-O ccRCC cell line. This autophagy can be inhibited by hydroxychloroquine. When treated with a combination of hydroxychloroquine and GW6471, the viability of the 786-O cells was decreased further when compared to the treatment with GW6471 or hydroxychloroquine alone, and apoptosis was promoted. Meanwhile, when human kidney 2 cells were cotreated with hydroxychloroquine and GW6471, cell viability was only slightly influenced. Hence, our finding indicates that the combination of GW6471 and hydroxychloroquine may constitute a novel and potentially effective treatment for ccRCC. Furthermore, this approach is likely to be safe owing to its minimal effects on normal renal tissues.http://dx.doi.org/10.1155/2021/6631605
spellingShingle Ruizhe Mao
Jian Shi
Xuyi Ma
Haiyan Xu
Hydroxychloroquine Potentiates Apoptosis Induced by PPARα Antagonist in 786-O Clear Cell Renal Cell Carcinoma Cells Associated with Inhibiting Autophagy
PPAR Research
title Hydroxychloroquine Potentiates Apoptosis Induced by PPARα Antagonist in 786-O Clear Cell Renal Cell Carcinoma Cells Associated with Inhibiting Autophagy
title_full Hydroxychloroquine Potentiates Apoptosis Induced by PPARα Antagonist in 786-O Clear Cell Renal Cell Carcinoma Cells Associated with Inhibiting Autophagy
title_fullStr Hydroxychloroquine Potentiates Apoptosis Induced by PPARα Antagonist in 786-O Clear Cell Renal Cell Carcinoma Cells Associated with Inhibiting Autophagy
title_full_unstemmed Hydroxychloroquine Potentiates Apoptosis Induced by PPARα Antagonist in 786-O Clear Cell Renal Cell Carcinoma Cells Associated with Inhibiting Autophagy
title_short Hydroxychloroquine Potentiates Apoptosis Induced by PPARα Antagonist in 786-O Clear Cell Renal Cell Carcinoma Cells Associated with Inhibiting Autophagy
title_sort hydroxychloroquine potentiates apoptosis induced by pparα antagonist in 786 o clear cell renal cell carcinoma cells associated with inhibiting autophagy
url http://dx.doi.org/10.1155/2021/6631605
work_keys_str_mv AT ruizhemao hydroxychloroquinepotentiatesapoptosisinducedbypparaantagonistin786oclearcellrenalcellcarcinomacellsassociatedwithinhibitingautophagy
AT jianshi hydroxychloroquinepotentiatesapoptosisinducedbypparaantagonistin786oclearcellrenalcellcarcinomacellsassociatedwithinhibitingautophagy
AT xuyima hydroxychloroquinepotentiatesapoptosisinducedbypparaantagonistin786oclearcellrenalcellcarcinomacellsassociatedwithinhibitingautophagy
AT haiyanxu hydroxychloroquinepotentiatesapoptosisinducedbypparaantagonistin786oclearcellrenalcellcarcinomacellsassociatedwithinhibitingautophagy